Goldman Sachs reports 1,228,500 shares (6.2%) in OACC
THE GOLDMAN SACHS GROUP, INC. and Goldman Sachs & Co. LLC report shared beneficial ownership of 1,228,500 Class A ordinary shares of OAKTREE ACQUISITION CORP III LIFE SCIENCES.
Rhea-AI Filing Summary
THE GOLDMAN SACHS GROUP, INC. and Goldman Sachs & Co. LLC report shared beneficial ownership of 1,228,500 Class A ordinary shares of OAKTREE ACQUISITION CORP III LIFE SCIENCES. The filing states this position represents 6.2% of the class as shown on the cover page, with related joint filing and subsidiary attribution disclosures.
Positive
- None.
Negative
- None.
Insights
Goldman Sachs group reports a material passive stake in OACC via shared voting/dispositive power.
The filing attributes ownership to Goldman Sachs Reporting Units and identifies Goldman Sachs & Co. LLC as the subsidiary holding the securities. The schedule is a passive ownership disclosure rather than an acquisition narrative.
Timing and cash‑flow treatment are not described in the excerpt; subsequent filings may clarify trading intent or changes in holdings.
Filing follows Rule 13d-1 joint filing conventions and includes parent/subsidiary attribution.
The submission includes a Joint Filing Agreement and Exhibit details assigning beneficial ownership to Goldman Sachs Reporting Units and noting disclaimers for client and managed-entity holdings. The document cites Release No. 34-39538 language for aggregation rules.
Regulatory qualifiers and the parent/subsidiary attribution are clear in the excerpt; monitoring amendments could show any ownership changes.
Key Figures
Key Terms
Joint Filing Agreement regulatory
parent holding company regulatory
beneficially owned financial
FAQ
What stake does Goldman Sachs report in OACC?
Which entities filed the Schedule 13G for OACC?
Is the ownership reported direct or through a subsidiary?
Does the filing claim control over client accounts or other managed entities?
AI-generated analysis. How Rhea-AI works. Not financial advice.